Measurement of antipyrine half‐life from urinary drug concentrations [letter]
- 1 October 1984
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 18 (4) , 650-652
- https://doi.org/10.1111/j.1365-2125.1984.tb02524.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.British Journal of Clinical Pharmacology, 1983
- Differential induction of antipyrine metabolism by rifampicinEuropean Journal of Clinical Pharmacology, 1981
- Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.British Journal of Clinical Pharmacology, 1979
- Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in ManPharmacology, 1979
- Assessment of antipyrine kinetics by measurement in saliva.British Journal of Clinical Pharmacology, 1976
- Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urineClinical Pharmacology & Therapeutics, 1975
- Elimination of antipyrine from saliva as a measure of metabolism in manClinical Pharmacology & Therapeutics, 1975
- DRUG URINARY EXCRETION DATA—SOME ASPECTS CONCERNING THE INTERPRETATIONBritish Journal of Pharmacology and Chemotherapy, 1967